Powered by

InMed Pharmaceuticals to Attend and Exhibit at EB2020 World Congress

Jan 16, 2020 - PR Newswire

PR Newswire

InMed Pharmaceuticals Inc. ("InMed" or "the Company") (TSX:IN; OTCQX:IMLFF), a clinical stage biopharmaceutical company developing cannabinoid-based medications targeting diseases with high unmet medical needs, today announced that members of its senior scientific and clinical team will be attending the EB2020 World Congress, organized and funded by the Dystrophic Epidermolysis Bullosa Research Association (DEBRA), from January 19-23, 2020 in London, UK.

InMed will...